India Vials Market to Grow with a CAGR of 4.60% through 2030

Expansion of the Pharmaceutical Industry and Surge in Demand for Injectable Drugs are expected to drive the India Vials Market growth in the forecast period, 2026-2030

According to TechSci Research report, “India Vials Market – By Region, Competition, Forecast & Opportunities, 2030F”, the India Vials Market stood at USD 655.76 Million in 2024 and is anticipated to grow with a CAGR of 4.60% in the forecast period, 2026-2030.

Ongoing innovations in vial manufacturing are significantly enhancing the safety, efficiency, and usability of vials. Key developments such as pre-filled syringes and specialized glass formulations are improving vial designs, while advancements like tamper-proof and break-resistant features address critical concerns related to product integrity and user safety. These improvements are particularly important in the handling of high-value biologic drugs, fueling the demand for modern vials that meet both pharmaceutical requirements and patient convenience.

India's pharmaceutical export market is also driving growth in the vial sector. As India's pharmaceutical exports continue to rise, particularly to developed markets like the United States and Europe, there is a heightened demand for high-quality vials that comply with stringent international standards. The global need for reliable packaging solutions for injectable drugs further supports the growth prospects for India's vial manufacturers, positioning them as key players in the global supply chain.

Regulatory frameworks, such as those established by the Central Drugs Standard Control Organization (CDSCO) and Good Manufacturing Practices (GMP), are encouraging manufacturers to uphold high standards in vial production. These regulations ensure product safety and boost consumer confidence, both domestically and internationally. Adherence to these standards positions manufacturers to meet the growing demands of the pharmaceutical industry. The rise in the adoption of biopharmaceuticals, particularly biologics such as monoclonal antibodies, gene therapies, and biosimilars, is another major driver. These therapies often require specialized packaging to preserve their efficacy, with pre-filled vials becoming increasingly popular to reduce contamination risks and enhance patient compliance. The rapid growth of the biologics market in India is contributing to the rising demand for vials tailored to these advanced therapies.

Advancements in vial materials are also playing a significant role in market growth. While glass vials remain dominant due to their inertness and superior quality, plastic and hybrid glass-plastic vials are gaining traction due to their lower production costs and reduced breakage risk. These material innovations are enabling manufacturers to offer cost-effective yet high-performance vial solutions, expanding the market's potential. The growing focus on patient-centric packaging is further driving the market. As the demand for home-based healthcare solutions increases, pre-filled vials and syringes are becoming essential for the self-administration of injectable drugs. These packaging solutions not only improve ease of use but also minimize medication errors, aligning with the increasing trend of patients managing their own treatments outside of clinical settings. This shift towards patient-centric packaging is a key factor fueling the demand for reliable and convenient vial solutions.

In the Indian vials market, the growing healthcare infrastructure and increasing demand for biologics and injectable medications are contributing to a surge in the adoption of both traditional and advanced vial solutions. Additionally, with the rise in home healthcare and self-medication trends, the demand for pre-filled vials and syringes is expected to see significant growth, further driving market expansion.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "India Vials Market”

The India Vials Market is segmented into preparation, application, material, end user, regional distribution, and company.

Based on its material, the Glass Vials segment has emerged as the predominant market leader, Glass vials continue to dominate the Indian vials market, holding a substantial share due to their long-standing use in the pharmaceutical industry and their superior material properties. Glass is considered the gold standard for pharmaceutical packaging, especially for injectable drugs, biologics, vaccines, and high-value medicines. The inert nature of glass ensures that it does not interact with the contents, maintaining the stability, efficacy, and sterility of drugs.

Glass is non-reactive, which is crucial for preserving the stability of pharmaceutical drugs, especially biologics and injectables, which are highly sensitive to contamination. This makes glass vials the preferred choice for high-value drugs. Glass vials meet the stringent regulatory requirements set by global standards, such as those from the FDA, EMA, and CDSCO. They are widely recognized for their high quality and safety, ensuring that manufacturers can meet international standards for pharmaceutical packaging. Glass is particularly favored for biologic drugs, monoclonal antibodies, and other high-cost medications that require optimal protection from light, moisture, and oxygen.

Major companies operating in India Vials Market are:

• Amcor Group
• Corning Incorporated
• Gerresheimer AG
• KISHORE GROUP
• Nipro Medical India Pvt. Ltd
• SCHOTT Glass India Pvt. Ltd.
• SGD Pharma
• MITSUBISHI GAS CHEMICAL COMPANY, INC

Download Free Sample Report

Customers can also request for 10% free customization on this report

“The India vials market is poised for continued growth, driven by a combination of factors including advancements in vial manufacturing technologies, the expanding pharmaceutical sector, increasing demand for injectable drugs, and the rise of biopharmaceuticals. While glass vials remain the dominant material due to their superior quality and chemical inertness, the growing popularity of polymer and hybrid vials reflects the industry's shift towards more cost-effective, durable, and patient-centric solutions. With strong regulatory frameworks in place and an increasing focus on global exports, India’s vial manufacturers are well-positioned to meet both domestic and international demand. As the market evolves, innovation in vial design and material technologies will be crucial in addressing the ever-changing needs of the pharmaceutical sector, ensuring that the India vials market remains a key player on the global stage,” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“India Vials Market, By Preparation (Ready to use (RTU), Ready to sterilize (RTS)), By Application (Small molecules, Biologics, Diagnostics), By Material (Glass, Polymer, Hybrid), By End User (Hospitals & clinics, Pharma & biotech companies, Contract development and manufacturing organizations (CDMOs), Diagnostic laboratories, Other), By Region, Competition, Forecast & Opportunities, 2020-2030F”, has evaluated the future growth potential of India Vials Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in India Vials Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]